The activity of axSpA ( BASDAI , Ankylosing Spondylitis Disease Activity Score ( ASDAS ) , erythrocyte sedimentation rate ( ESR ) , and high-sensitivity C-reactive protein ( hs-CRP ) ) was evaluated at baseline , @ and @ weeks ; adverse events were recorded at baseline , @ , @ , and @ weeks .